Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. (Q47308234)
Jump to navigation
Jump to search
scientific article published in January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. |
scientific article published in January 2007 |
Statements
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not (English)
Kirsten Raun
Pia von Voss
Carsten F Gotfredsen
Valeria Golozoubova
1 January 2007